• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,285.07 521.16
( 0.67%)
Global Indices
Nasdaq
52,921.07 594.83
(1.14%)
Dow Jones
7,504.24 0.01
(0.00%)
Hang Seng
69,576.15 -167.92
(-0.24%)
Nikkei 225
10,649.07 -29.96
(-0.28%)
Forex
USD-INR
95.28 0.28
(0.30%)
EUR-INR
108.75 0.54
(0.50%)
GBP-INR
126.99 1.06
(0.84%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Tata Consultancy Services Ltd
Industry :  Computers - Software - Large
BSE Code
ISIN Demat
Book Value()
532540
INE467B01029
234.0734112
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TCS
14.5
757175.27
EPS(TTM)
Face Value()
Div & Yield %
144.34
1
5.26
 

ANG Lifesciences India reports consolidated net loss of Rs 1.38 crore in the March 2026 quarter
Jun 01,2026
Net Loss of ANG Lifesciences India reported to Rs 1.38 crore in the quarter ended March 2026 as against net loss of Rs 2.06 crore during the previous quarter ended March 2025. Sales rose 39.71% to Rs 23.50 crore in the quarter ended March 2026 as against Rs 16.82 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 11.08 crore in the year ended March 2026 as against net loss of Rs 12.41 crore during the previous year ended March 2025. Sales rose 0.04% to Rs 92.89 crore in the year ended March 2026 as against Rs 92.85 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales23.5016.82 40 92.8992.85 0
OPM %11.36-4.16 -0.76-2.44 -
PBDT0.67-2.47 LP -6.68-8.94 25
PBT-1.10-3.89 72 -13.01-15.70 17
NP-1.38-2.06 33 -11.08-12.41 11